Orbimed-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
107
Total Value
4035711615
Accession Number
0001172661-25-002355
Form Type
13F-HR
Manager Name
Orbimed-Advisors
Data Enrichment
92% identified
98 identified9 unidentified

Holdings

107 positions • $4.0B total value
Manager:
Search and click to pin securities to the top
Page 1 of 6
P8696W104
Shares:2.7M
Value:$334.0M
% of Portfolio:8.3% ($334.0M/$4.0B)
Edgewise Therapeutics, Inc.
Shares:15.0M
Value:$330.5M
% of Portfolio:8.2% ($330.5M/$4.0B)
BOSTON SCIENTIFIC CORP
Shares:2.8M
Value:$283.8M
% of Portfolio:7.0% ($283.8M/$4.0B)
ELI LILLY & Co
Shares:337.6K
Value:$278.8M
% of Portfolio:6.9% ($278.8M/$4.0B)
Enliven Therapeutics, Inc.
Shares:8.0M
Value:$156.6M
% of Portfolio:3.9% ($156.6M/$4.0B)
INTUITIVE SURGICAL INC
Shares:291.0K
Value:$144.1M
% of Portfolio:3.6% ($144.1M/$4.0B)
STRYKER CORP
Shares:359.2K
Value:$133.7M
% of Portfolio:3.3% ($133.7M/$4.0B)
ARGENX SE
Shares:206.7K
Value:$122.3M
% of Portfolio:3.0% ($122.3M/$4.0B)
Edwards Lifesciences Corp
Shares:1.5M
Value:$111.0M
% of Portfolio:2.8% ($111.0M/$4.0B)
UNITEDHEALTH GROUP INC
Shares:201.2K
Value:$105.4M
% of Portfolio:2.6% ($105.4M/$4.0B)
ARS Pharmaceuticals, Inc.
Shares:8.3M
Value:$104.3M
% of Portfolio:2.6% ($104.3M/$4.0B)
NEUROCRINE BIOSCIENCES INC
Shares:934.6K
Value:$103.4M
% of Portfolio:2.6% ($103.4M/$4.0B)
ALNYLAM PHARMACEUTICALS, INC.
Shares:346.1K
Value:$93.5M
% of Portfolio:2.3% ($93.5M/$4.0B)
Integer Holdings Corp
Shares:662.5K
Value:$78.2M
% of Portfolio:1.9% ($78.2M/$4.0B)
VERTEX PHARMACEUTICALS INC / MA
Shares:159.9K
Value:$77.5M
% of Portfolio:1.9% ($77.5M/$4.0B)
Natera, Inc.
Shares:547.0K
Value:$77.4M
% of Portfolio:1.9% ($77.4M/$4.0B)
IONIS PHARMACEUTICALS INC
Shares:2.5M
Value:$76.6M
% of Portfolio:1.9% ($76.6M/$4.0B)
Disc Medicine, Inc.
Shares:1.4M
Value:$70.2M
% of Portfolio:1.7% ($70.2M/$4.0B)
THERMO FISHER SCIENTIFIC INC.
Shares:129.0K
Value:$64.2M
% of Portfolio:1.6% ($64.2M/$4.0B)
TENET HEALTHCARE CORP
Shares:465.0K
Value:$62.5M
% of Portfolio:1.5% ($62.5M/$4.0B)